Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Novel radiolabeled antibody conjugates
2007
Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients
2003
Preparation and characterization of paramagnetic polychelates and their protein conjugates
1990
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
1991 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma
2005
Cancer to bone: a fatal attraction
2011 Standout
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
1997 StandoutNobel
Medullary Thyroid Cancer
1995
Use of radionuclides for the palliation of bone metastases
2000
In vitro and in vivo evaluation of novel ligands for radioimmunotherapy
2006
Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity
1994 StandoutNobel
Phaeochromocytoma
2005 Standout
Cancer Statistics, 2006
2006 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems
2002
Improving de novo protein binder design with deep learning
2023 StandoutNobel
Photosensitizer-antibody conjugates for detection and therapy of cancer
2003
Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers
1998
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Medullary Thyroid Carcinoma
2007
The targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model
2008
Expression of an antibody Fv fragment in myeloma cells
1988 StandoutNobel
Polylysine-Gd-DTPAn and Polylysine-Gd-DOTAn Coupled to Anti-CEA F(ab′)2 Fragments as Potential Immunocontrast Agents
1998
Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level
2005
Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles
1992
Polyphosphoric acid capping radioactive/upconverting NaLuF4:Yb,Tm,153Sm nanoparticles for blood pool imaging in vivo
2013
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer
1998
Localization of Medullary Thyroid Carcinoma Metastasis in a Multiple Endocrine Neoplasia Type 2A Patient by 6-[18F]-Fluorodopamine Positron Emission Tomography
2003
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
2000
Anti‐carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Antibody-based imaging strategies for cancer
2014
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
2004
Radioimmunotherapy of non-Hodgkin’s lymphoma: a critical appraisal
2005
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Hematopoietic Stem-Cell Transplantation
2006 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
A comparison of radiopharmaceutical agents used for the diagnosis of pulmonary embolism
2001
Monoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
1989
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Mechanisms of Bone Metastasis
2004 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Prevention of manifest metastasis with monoclonal antibodies: A novel approach to immunotherapy of solid tumours
1995
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.
1987
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
1994 StandoutNobel
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
An evaluation of Technegas as a ventilation agent compared with krypton-81 m in the scintigraphic diagnosis of pulmonary embolism
1992
Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
1989
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
2003
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
Reversibly thermo-responsive alkyl-terminated poly(N-isopropylacrylamide) core-shell micellar structures
1997
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-dl-lactide)
1998
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
1999 Standout
Experimental tumor targeting with radiolabeled ligands
1997
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Diagnosis of Pheochromocytoma
1988
Tumor cure probability during alpha-RIT of ovarian cancer with different radiation sensitivity.
2010
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
2002
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Stimuli-reponsive polymers and their bioconjugates
2004 Standout
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
2006
Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
1986
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Molecular imaging and gene therapy.
2001
Dendrimers—Branching out from curiosities into new technologies
1998 StandoutNobel
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer.
2005
About Dendrimers: Structure, Physical Properties, and Applications
1999 Standout
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
TARGETED CONTRAST AGENTS IN MR IMAGING
1996
Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group
2006
Antigenic sites in carcinoembryonic antigen
1990
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
2002
Molecular Dynamics of Ion−Chelate Complexes Attached to Dendrimers
1996 StandoutNobel
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Improved Tumor Selectivity of Radiolabeled Peptides by Receptor and Antigen Dual Targeting in the Neurotensin Receptor Model
2002
Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
2003
The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model
2004
Passage of Inhaled Particles Into the Blood Circulation in Humans
2002 Standout
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels
2007
An antibody-desferrioxamine conjugate labelled with 67Ga
1986
Stereoselective synthesis of the C-analogue of β-d-glucopyranosyl serine
1997 StandoutNobel
Surface molecular recognition
2001 StandoutNobel
Site-Specific Polymer−Streptavidin Bioconjugate for pH-Controlled Binding and Triggered Release of Biotin
1999
Works of J.F. Chatal being referenced
Cell death induced by a 131I-labeled monoclonal antibody in ovarian cancer multicell spheroids
1996
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer
2005
Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres
1994
Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody
1990
Radionuclide therapy practice and facilities in Europe
1999
A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase
1997
Biodistribution of anti-CEA F(ab′)2 fragments conjugated with chelating polymers: Influence of conjugate electron charge on tumor uptake and blood clearance
1993
Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: Effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma
1992
Comparison of technetium-99m aerosol and krypton-81m in ventilation studies for the diagnosis of pulmonary embolism
1990
Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab?)2 fragments
1990
Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
1992
Nuclear Medicine Applications for Neuroendocrine Tumors
2000
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.
1983
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
1993
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
1999
A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma.
1999
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
1986
Radioimmunotherapy in non-Hodgkin's lymphoma (NHL) using a fractionated schedule of DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab
2004
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial.
1999
Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.
1993
Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
1989
Immunoscintigraphy of colon carcinoma.
1984
Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.
1999